CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $94,760 | +20.5% | 11,670 | +28.8% | 0.00% | 0.0% |
| Q1 2021 | $78,658 | -5.9% | 9,062 | -13.6% | 0.00% | 0.0% |
| Q4 2020 | $83,565 | -0.1% | 10,485 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $83,618 | -19.4% | 10,485 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $103,802 | +85.3% | 10,485 | +23.7% | 0.00% | +100.0% |
| Q2 2019 | $56,033 | -12.7% | 8,477 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $64,171 | -23.9% | 8,477 | -18.8% | 0.00% | -50.0% |
| Q4 2018 | $84,371 | -37.4% | 10,442 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $134,702 | -99.9% | 10,442 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $119,039,000 | – | 10,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |